Brandinium

Trademark search for:

BOSTON BIOMEDICAL

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2013-11-05 — Application filed
  • 2013-11-08 — Application filed
  • 2013-11-08 — Teas voluntary amendment received
  • 2013-11-12 — Assigned to lie
  • 2013-11-15 — Application filed
  • 2013-11-18 — Correspondence received in law office
  • 2013-11-18 — Teas/email correspondence entered
  • 2014-02-21 — Assigned to examiner
  • 2014-03-01 — Final disposition recorded
  • 2014-03-01 — Final disposition recorded
  • 2014-03-04 — Final disposition recorded
  • 2014-04-07 — Teas/email correspondence entered
  • 2014-04-07 — Office action issued
  • 2014-04-07 — Correspondence received in law office
  • 2014-04-07 — Approved for pub - principal register
  • 2014-04-14 — Assigned to lie
  • 2014-04-14 — Law office publication review completed
  • 2014-04-30 — Notice of publication
  • 2014-05-20 — Published for opposition
  • 2014-08-05 — Registered-principal register
  • 2014-12-03 — Automatic update of assignment of ownership
  • 2015-09-04 — Teas revoke/app/change addr of atty/dom rep received
  • 2015-09-04 — Attorney/dom.rep.revoked and/or appointed
  • 2019-08-05 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2019-11-20 — Teas section 8 & 15 received
  • 2020-01-13 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2020-01-13 — Case assigned to post registration paralegal
  • 2020-01-13 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2023-08-05 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2025-02-21 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2025-02-21 — Final status recorded

Owner Information

SUMITOMO DAINIPPON PHARMA CO., LTD.
OSAKA JP
Dainippon Sumitomo Pharma Co., Ltd.
Osaka-shi, Osaka JP
Dainippon Sumitomo Pharma Co., Ltd.
Osaka-shi, Osaka JP
Dainippon Sumitomo Pharma Co., Ltd.
Osaka-shi, Osaka JP

Correspondent

Rebeccah Gan WENDEROTH LLP
1025 CONNECTICUT AVENUE NW SUITE 500
WASHINGTON, DC 20036
UNITED STATES

Filing Details

Filing Date:
2013-11-05
Status Date:
2025-02-21
Filing Year:
2012

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.